The industrial point of view: Competence development in pharmaceutical industry

被引：0

|

作者：

Jansson, SO

Vessman, J

机构：

来源：

AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION | 1997年 / 61卷 / 02期

关键词：

D O I：

暂无

中图分类号：

G40 [教育学];

学科分类号：

040101 ; 120403 ;

摘要：

引用

收藏

页码：202 / 203

页数：2

相关论文

共 50 条

[1] Methodology and complexity of megatrials:: Point-of-view of the pharmaceutical industry
Hernández, G
[J]. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2001, 23 (06): : 295 - 295
[2] The FDA guidance for industry on PROs: the point of view of a pharmaceutical company
Fabio Arpinelli
Francesco Bamfi
[J]. Health and Quality of Life Outcomes, 4
[3] Medical information services from the point of view of the pharmaceutical industry
Mecker, G
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 693 - 693
[4] The FDA guidance for industry on PROs: the point of view of a pharmaceutical company
Arpinelli, Fabio
Bamfi, Francesco
[J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2006, 4 (1)
[5] Marine technology development - An 'industrial' point of view
Peterson, K
[J]. SEA TECHNOLOGY, 1996, 37 (07) : 97 - 97
[6] CONSEQUENCES OF PATENTABILITY ON PHARMACEUTICAL-INDUSTRY - THE POINT OF VIEW OF A PATENT ATTORNEY
BIANCHETTI, G
[J]. CHIMICA & L INDUSTRIA, 1982, 64 (7-8): : 501 - 505
[7] A contribution to performance measurement in the healthcare industry: the industrial point of view
Schaefers, Jos
Colin, Jerome
Aggoune, Riad
Kucina, Myriam
[J]. INTERNATIONAL JOURNAL OF BUSINESS PERFORMANCE MANAGEMENT, 2007, 9 (02) : 226 - 239
[8] POINTS OF VIEW ON PHARMACEUTICAL INDUSTRY
HURLIMAN.A
[J]. BULLETIN DER SCHWEIZERISCHEN AKADEMIE DER MEDIZINISCHEN WISSENSCHAFTEN, 1973, 29 (1-3): : 65 - 69
[9] A view from the pharmaceutical industry
Peroutka, SJ
[J]. NEUROLOGIST, 1995, 1 (01) : 65 - 68
[10] THE VIEW OF THE PHARMACEUTICAL-INDUSTRY
ROCHE, G
HELENPORT, JP
[J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1994, 88 : 57 - 58

← 1 2 3 4 5 →